Published in Ther Adv Drug Saf on October 01, 2013
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporos Int (2015) 0.81
Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr Res (2016) 0.80
Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. PLoS One (2016) 0.76
Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Osteoporos Int (2015) 0.76
The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients. Clin Epidemiol (2015) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Publication bias in clinical research. Lancet (1991) 22.85
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Osteoporosis prevention, diagnosis, and therapy. JAMA (2001) 12.60
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ (2010) 10.85
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet (2007) 9.61
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Full publication of results initially presented in abstracts. Cochrane Database Syst Rev (2007) 7.52
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA (1991) 6.05
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05
Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 4.39
The challenge of subgroup analyses--reporting without distorting. N Engl J Med (2006) 4.19
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med (2006) 4.09
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ (2005) 4.04
Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr (2010) 3.86
The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med (2002) 2.86
Effect of calcium supplementation on hip fractures. Osteoporos Int (2008) 2.79
Randomized controlled trial of calcium in healthy older women. Am J Med (2006) 2.78
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2009) 2.58
Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet (1973) 2.46
Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke (1999) 2.41
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int (2007) 2.40
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
The calcium scare--what would Austin Bradford Hill have thought? Osteoporos Int (2011) 2.35
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ (2013) 2.17
Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res (2011) 2.08
Cardiovascular effects of calcium supplementation. Osteoporos Int (2011) 1.96
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Calcium supplementation of the diet--II. BMJ (1989) 1.85
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med (1998) 1.81
Calcium supplementation: balancing the cardiovascular risks. Maturitas (2011) 1.56
Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ (2011) 1.53
A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr (2003) 1.52
Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. Int J Epidemiol (1992) 1.49
Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr (1993) 1.45
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res (2007) 1.45
Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf) (2010) 1.44
Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: should we change our approach to bone health? Ann Pharmacother (2012) 1.42
Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin (2007) 1.39
Reversals of established medical practices: evidence to abandon ship. JAMA (2012) 1.38
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (2009) 1.34
Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs (2012) 1.30
Do calcium plus vitamin D supplements increase cardiovascular risk? BMJ (2011) 1.25
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab (2008) 1.14
Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res (2012) 1.07
Calcium intake and fracture risk: results from the study of osteoporotic fractures. Am J Epidemiol (1997) 1.07
A review of calcium supplements and cardiovascular disease risk. Adv Nutr (2012) 0.94
Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One (2013) 0.94
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int (2011) 0.91
Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int (2003) 0.90
Re: The calcium scare: what would Austin Bradford Hill have thought? Osteoporos Int (2011) 0.89
Calcium supplementation increases circulating cholesterol by reducing its catabolism via GPER and TRPC1-dependent pathway in estrogen deficient women. Int J Cardiol (2013) 0.86
Authors' response to editorial. BMJ (2011) 0.86
Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab (2011) 0.85
Commentary on calcium supplements and cardiovascular events. J Clin Densitom (2012) 0.85
The impact of dietary calcium intake and vitamin D status on the effects of zoledronate. Osteoporos Int (2012) 0.84
Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey Rep (2013) 0.83
An inappropriate response? BMJ (2013) 0.80
Misclassification does not explain increased cardiovascular risks of calcium supplements. J Bone Miner Res (2012) 0.78
Climacteric commentaries. Calcium and vitamin D in heart disease. Climacteric (2012) 0.76
What is the appropriate MHRA regulatory response to calcium's increased cardiovascular risk? BMJ (2013) 0.76
Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med (2002) 2.86
Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol (2014) 2.85
Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. J Clin Densitom (2016) 1.47
Responses of specialist societies to evidence for reversal of practice. JAMA Intern Med (2015) 1.18
How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open (2014) 1.09
Vitamin D Supplements and the Risk of Falls. JAMA Intern Med (2015) 1.09
Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91
Reporting of Limitations of Observational Research. JAMA Intern Med (2015) 0.88
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. Clin Genitourin Cancer (2014) 0.84
Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One (2014) 0.82
Evidence for a role for the p110-alpha isoform of PI3K in skeletal function. Biochem Biophys Res Commun (2009) 0.82
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record. BMJ Open (2014) 0.81
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial. J Bone Miner Res (2014) 0.80
Clinical trial evidence and use of fish oil supplements. JAMA Intern Med (2014) 0.78
Skeletal health in adults with HIV infection. Lancet Diabetes Endocrinol (2014) 0.78
Management recommendations for osteoporosis in clinical guidelines. Clin Endocrinol (Oxf) (2016) 0.77
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open (2015) 0.76
Postmenopausal osteoporosis. Nat Rev Dis Prim (2016) 0.76
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. PLoS One (2016) 0.75
Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry. BMJ Open (2017) 0.75
Calcium supplements associated with increased risk of cardiovascular death in men but not women. Evid Based Nurs (2013) 0.75
Zoledronate: efficacy and safety. J Bone Miner Res (2006) 0.75
Lysophosphatidic Acid Is an Osteoblast Mitogen Whose Proliferative Actions Involve Gi Proteins and Protein Kinase C, But Not P42/44 Mitogen-Activated Protein Kinases. Endocrinology (2001) 0.75
The Impact of 3-D Models versus Animations on Perceptions of Osteoporosis and Treatment Motivation: A Randomised Trial. Ann Behav Med (2017) 0.75
Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study. BMJ Open (2017) 0.75
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial. CMAJ (2017) 0.75
Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy. Calcif Tissue Int (2019) 0.75